Clinical trial

Beta3 Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure

NCT02775539

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-06-01

PhasePHASE2

Study timeline

Study start (unknown)2016-06-01Date precision: month

Registry last updated2016-05-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Hypertensionunresolved

Mirabegronunresolved

Heart Failureunresolved

Pulmonary Vascular Resistance Abnormalityunresolved

Interventions

MirabegronDRUG · verified · RxNorm: mirabegron

Sponsors & collaborators

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIIlead sponsor

Hospital Clinic of Barcelonacollaborator

Hospital Universitario 12 de Octubrecollaborator

Puerta de Hierro University Hospitalcollaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Paucollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02775539 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.